ASX Announcement – 27 October 2026 $6.0 MILLION PLACEMENT OVERSUBSCRIBED BALANCE SHEET STRENGTHENED TO FUND THREE GROWTH PROGRAMMES Highlights • Firm commitments received for a $6.0M placement to institutional, professional + sophisticated investors at 7.2 cents per share, a 6.4% discount to...
$6.0 Million Placement Oversubscribed
Filed with ASX ·
6ix is reading this filing.
Earlier from Resonance Health
- Liver Fibrosis Device - EPoC Study Results
- Trading Halt
- Global Strategic Alliance & MSA with Image Analysis Group
- FY26 Full Year Results & Investor Webinar
- Liver Fibrosis Device Progress & FY26 Portfolio Webinar
Later from Resonance Health
- Investor Presentation Liver Fibrosis Device & Capital Raise
- Liver Fibrosis Device Webinar Presentation
